Cargando…

Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality

PURPOSE: To investigate the possible associations between serum levels of soluble receptor for advanced glycation end products (sRAGE) and specific clinical markers and prognosis in critically ill patients diagnosed with stress hyperglycemia. PATIENTS AND METHODS: A total of 70 critically ill patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Yanzi, Zhong, Jiwen, Xiang, Yang, Zeng, Fan, Cai, Dehong, Zhao, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242067/ https://www.ncbi.nlm.nih.gov/pubmed/25429209 http://dx.doi.org/10.2147/CIA.S71130

Ejemplares similares

High 28-day mortality in critically ill patients with sepsis and concomitant active cancer
por: Wang, Yong-gang, et al.
Publicado: (2018)

Albumin–Globulin Ratio Is an Independent Determinant of 28-Day Mortality in Patients with Critical Illness
por: Liu, Bin, et al.
Publicado: (2021)

Receptor for advanced glycation end products axis in critically ill patients
por: Ingels, C, et al.
Publicado: (2014)

Brainstem response patterns in deeply-sedated critically-ill patients predict 28-day mortality
por: Rohaut, Benjamin, et al.
Publicado: (2017)

Gut bacteriobiota and mycobiota are both associated with Day-28 mortality among critically ill patients
por: Prevel, Renaud, et al.
Publicado: (2022)

Association between incident delirium and 28- and 90-day mortality in critically ill adults: a secondary analysis
por: Duprey, Matthew S., et al.
Publicado: (2020)

Using machine learning algorithms to predict 28-day mortality in critically ill elderly patients with colorectal cancer
por: Guo, Chunxia, et al.
Publicado: (2023)

The Impact of CoronaVac Vaccination on 28-day Mortality Rate of Critically Ill Patients with COVID-19 in Türkiye
por: Gül, Fethi, et al.
Publicado: (2023)

The association between nutritional adequacy and 28-day mortality in the critically ill is not modified by their baseline nutritional status and disease severity
por: Lew, Charles Chin Han, et al.
Publicado: (2019)

Clinical Characteristics and Predictors of 28-Day Mortality in 352 Critically Ill Patients with COVID-19: A Retrospective Study
por: Alharthy, Abdulrahman, et al.
Publicado: (2021)

Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients
por: Assiri, Adel M. A., et al.
Publicado: (2018)

Soluble receptor for advanced glycation end-products and progression of airway disease
por: Iwamoto, Hiroshi, et al.
Publicado: (2014)

Circulating soluble receptor for advanced glycation end products and other factors in type 2 diabetes patients with colorectal cancer
por: Zhou, Xiaohai, et al.
Publicado: (2020)

Association between Malnutrition and 28-Day Mortality and Intensive Care Length-of-Stay in the Critically ill: A Prospective Cohort Study
por: Lew, Charles Chin Han, et al.
Publicado: (2017)

Red Blood Cell Distribution Width as a Predictor of 28‐Day Mortality in Critically Ill Patients With Alcohol Use Disorder
por: Liao, Lin, et al.
Publicado: (2020)

Clinical characteristics and risk factors for 28-day mortality in critically ill patients with COVID-19: a retrospective cohort study
por: YAKAR, Mehmet Nuri, et al.
Publicado: (2021)

Prediction of 28-day mortality in critically ill patients with COVID-19: Development and internal validation of a clinical prediction model
por: Leoni, Matteo Luigi Giuseppe, et al.
Publicado: (2021)

Performance of NUTRIC score to predict 28-day mortality in critically ill patients after replacing APACHE II with SAPS 3
por: Souza, Ivens Augusto Oliveira, et al.
Publicado: (2022)

Early glycaemic variability increases 28-day mortality and prolongs intensive care unit stay in critically ill patients with pneumonia
por: Kim, Seong Ho, et al.
Publicado: (2022)

Association between early nutrition support and 28-day mortality in critically ill patients: the FRANS prospective nutrition cohort study
por: Pardo, Emmanuel, et al.
Publicado: (2023)

Intra-abdominal Pressure Has a Good Predictive Power for 28-Day Mortality: A Prospective Observational Study Conducted in Critically Ill Children
por: Liang, Yujian, et al.
Publicado: (2020)

Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques
por: Pinto, Raphael S, et al.
Publicado: (2022)

Endothelial Microvesicles and Soluble Markers of Endothelial Injury in Critically Ill Newborns
por: Vítková, Veronika, et al.
Publicado: (2018)

Soluble vascular endothelial cadherin: a promising marker of critical illness?
por: Zhang, Ruyuan, et al.
Publicado: (2019)

The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases
por: Steenbeke, Mieke, et al.
Publicado: (2022)

Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD
por: Dozio, Elena, et al.
Publicado: (2020)

Advanced glycation end products and diabetes and other metabolic indicators
por: Jiang, Tian, et al.
Publicado: (2022)

Protective Effects of the Soluble Receptor for Advanced Glycation End-Products on Pyroptosis during Myocardial Ischemia-Reperfusion
por: Liu, Yingming, et al.
Publicado: (2021)

28-day prognostic value of coronary artery calcification burden in critically ill patients with COVID-19
por: de Pádua Gomes de Farias, Lucas, et al.
Publicado: (2023)

Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome
por: Jensen, Louise J. N., et al.
Publicado: (2015)

Decreased Soluble Receptor of Advanced Glycation End Product Levels Correlated with Inflammation in Silicosis
por: Liu, Heliang, et al.
Publicado: (2020)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
por: Pratte, Katherine A., et al.
Publicado: (2021)

Soluble Receptor for Advanced Glycation End-products regulates age-associated Cardiac Fibrosis
por: Scavello, Francesco, et al.
Publicado: (2021)

Atrial fibrillation is not an independent determinant of 28-day mortality among critically III sepsis patients
por: Wang, Weiping, et al.
Publicado: (2023)

Hyperglycaemia in critically ill patients: marker or mediator of mortality?
por: Corstjens, Anouk M, et al.
Publicado: (2006)

Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor
por: Rzepka, Rafał, et al.
Publicado: (2015)

Optimal Nutritional Support Strategy Based on the Association between Modified NUTRIC Score and 28-Day Mortality in Critically Ill Patients: A Prospective Study
por: Park, Sunny, et al.
Publicado: (2023)

Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients
por: Dozio, Elena, et al.
Publicado: (2018)

Genetically Modified Circulating Levels of Advanced Glycation End-Products and Their Soluble Receptor (AGEs-RAGE Axis) with Risk and Mortality of Breast Cancer
por: Peng, Yu, et al.
Publicado: (2022)

Negative fluid balance 48 hours after admission improves survival at 28 days in critically ill patients
por: Cuartero, M, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_smvsn1vcni8otgumhco6mt4k0j